Cravath represented the underwriters, led by Credit Suisse, Citi and RBS, in connection with the US$1.5 billion registered investment grade senior debt offering of Express Scripts, Inc., one of the largest Pharmacy Benefit Management companies in North America. The transaction closed on May 2, 2011.
The Cravath team included partner William J. Whelan III on corporate matters and partner Andrew W. Needham on tax matters.